[go: up one dir, main page]

DE60304065D1 - Optimierte proteinsynthese - Google Patents

Optimierte proteinsynthese

Info

Publication number
DE60304065D1
DE60304065D1 DE60304065T DE60304065T DE60304065D1 DE 60304065 D1 DE60304065 D1 DE 60304065D1 DE 60304065 T DE60304065 T DE 60304065T DE 60304065 T DE60304065 T DE 60304065T DE 60304065 D1 DE60304065 D1 DE 60304065D1
Authority
DE
Germany
Prior art keywords
protein synthesis
optimized protein
optimized
vitro
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60304065T
Other languages
English (en)
Inventor
Manfred Watzele
Bernd Buchberger
Michael Paulus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Priority to DE60304065T priority Critical patent/DE60304065D1/de
Application granted granted Critical
Publication of DE60304065D1 publication Critical patent/DE60304065D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60304065T 2002-12-09 2003-12-09 Optimierte proteinsynthese Expired - Fee Related DE60304065D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE60304065T DE60304065D1 (de) 2002-12-09 2003-12-09 Optimierte proteinsynthese

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10257479A DE10257479A1 (de) 2002-12-09 2002-12-09 Optimierte Proteinsynthese
PCT/EP2003/013964 WO2004053053A2 (de) 2002-12-09 2003-12-09 Optimierte proteinsynthese
DE60304065T DE60304065D1 (de) 2002-12-09 2003-12-09 Optimierte proteinsynthese

Publications (1)

Publication Number Publication Date
DE60304065D1 true DE60304065D1 (de) 2006-05-11

Family

ID=32403731

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10257479A Withdrawn DE10257479A1 (de) 2002-12-09 2002-12-09 Optimierte Proteinsynthese
DE60304065T Expired - Fee Related DE60304065D1 (de) 2002-12-09 2003-12-09 Optimierte proteinsynthese

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10257479A Withdrawn DE10257479A1 (de) 2002-12-09 2002-12-09 Optimierte Proteinsynthese

Country Status (8)

Country Link
US (1) US20060264612A1 (de)
EP (1) EP1570062B1 (de)
JP (1) JP2006508672A (de)
AT (1) ATE320499T1 (de)
AU (1) AU2003298958A1 (de)
CA (1) CA2507141A1 (de)
DE (2) DE10257479A1 (de)
WO (1) WO2004053053A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2573113A1 (en) * 2004-07-26 2006-02-09 Enzon Pharmaceuticals, Inc. Optimized interferon-beta gene
US9005920B2 (en) 2009-06-15 2015-04-14 Toyota Jidosha Kabushiki Kaisha Solution for cell-free protein synthesis, kit for cell-free protein synthesis, and method of protein synthesis
GB202207818D0 (en) * 2022-05-27 2022-07-13 Nuclera Nucleics Ltd Linear nucleic acid expression constructs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000604A1 (en) * 1987-07-13 1989-01-26 Interferon Sciences, Inc. Method for improving translation efficiency

Also Published As

Publication number Publication date
EP1570062B1 (de) 2006-03-15
EP1570062A2 (de) 2005-09-07
ATE320499T1 (de) 2006-04-15
WO2004053053A2 (de) 2004-06-24
JP2006508672A (ja) 2006-03-16
AU2003298958A1 (en) 2004-06-30
CA2507141A1 (en) 2004-06-24
WO2004053053A3 (de) 2004-09-30
US20060264612A1 (en) 2006-11-23
DE10257479A1 (de) 2004-07-01
AU2003298958A8 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
PT1644484E (pt) Células autólogas de indução de auto-tolerância de origem monocítica e sua utilização em preparações farmacêuticas
NO20042159L (no) Cellokulturprosess
DE60335733D1 (de) Verfahren zur solubilisierung von protein
DE60207053D1 (de) Rekombinante gelatineartige proteine zur verwendung als plasmaexpander
DE60228847D1 (de)
AU2003209059A1 (en) Human monoclonal antibodies against membrane proteins
GB0208041D0 (en) Method of culturing animal cells
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
AU2003298523A8 (en) Methods for efficient production of mammalian recombinant proteins
WO2004081033A3 (en) Synthesis of proteins by cell-free protein expression
ATE320499T1 (de) Optimierte proteinsynthese
EP1366360A4 (de) Verfahren zum proteinvergleich im grossmassstab
EE05634B1 (et) Geneetiline test kompleksset selgroo v„„rarengut kandvate veiste tuvastamiseks
AU7274801A (en) General means of labeling protein by using wheat embryo cell-free protein synthesis system
WO2002052270A3 (en) Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
EP1548443A4 (de) Teststück für protein-assay und prozess zu seiner herstellung
AU2003209735A1 (en) Filament-recruiting fluorescent proteins for the analysis and identification of protein-protein-interactions
ATE505538T1 (de) Dna-vektoren
AU2003226907A8 (en) Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
ATE392480T1 (de) Verfahren zur vorhersage der expressionseffizienz in zellfreien expressionssystemen
NO20053829L (no) Fremgangsmate og intermediater for fremstilling av olanzapin.
MY142798A (en) Methods for preventing glyconoylation of proteins
ATE433953T1 (de) Peptiddeformylaseinhibitoren
IT1298437B1 (it) Procedimento per la produzione di proteine/peptidi tossici
BR0303226A (pt) Proteìnas de aderência e penetração de haemophilus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee